- You are here: Home
- Disease Models
- Orthopedic Disease Models
- Osteoporosis Model
Disease Models
- Oncology Models
-
Inflammation & Autoimmune Disease Models
- Rheumatoid Arthritis Models
- Glomerulonephritis Models
- Multiple Sclerosis (MS) Models
- Ocular Inflammation Models
- Sjögren's Syndrome Model
- LPS-induced Acute Lung Injury Model
- Peritonitis Models
- Passive Cutaneous Anaphylaxis Model
- Delayed-Type Hypersensitivity (DTH) Models
- Inflammatory Bowel Disease Models
- Systemic Lupus Erythematosus Animal Models
- Asthma Model
- Sepsis Model
- Psoriasis Model
- Atopic Dermatitis (AD) Model
- Scleroderma Model
- Gouty Arthritis Model
- Carrageenan-Induced Air Pouch Synovitis Model
- Carrageenan-Induced Paw Edema Model
- Experimental Autoimmune Myasthenia Gravis (EAMG) Model
- Cardiovascular Disease Models
-
Neurological Disease Models
- Alzheimer's Disease Modeling and Assays
- Seizure Models
- Parkinson's Disease Models
- Ischemic Stroke Models
- Acute Spinal Cord Injury (ASCI) Model
- Traumatic Brain Injury (TBI) Model
- Hypoxic-Ischemic Encephalopathy (HIE) Model
- Tourette Syndrome (TS) Model
- Amyotrophic Lateral Sclerosis (ALS) Model
- Huntington's Disease (HD) Model
- Intracerebral hemorrhage (ICH) Models
- Pain Models
- Metabolic Disease Models
- Liver Disease Models
- Rare Disease Models
- Respiratory Disease Models
- Digestive Disease Models
-
Urology Disease Models
- Cisplatin-induced Nephrotoxicity Model
- Unilateral Ureteral Obstruction Model
- 5/6 Nephrectomy Model
- Renal Ischemia-Reperfusion Injury (RIRI) Model
- Diabetic Nephropathy (DN) Models
- Passive Heymann Nephritis (PHN) Model
- Adenine-Induced Chronic Kidney Disease (CKD) Model
- Kidney Stone Model
- Doxorubicin-Induced Nephropathy Model
- Orthopedic Disease Models
- Ocular Disease Models
Osteoporosis Model
Creative Bioarray specializes in providing various osteoporosis models tailored for preclinical research. Our team of experts employs cutting-edge techniques to develop and validate these models, ensuring their relevance and reliability for your research needs. Whether you are studying the effects of investigating the mechanisms of glucocorticoid-induced osteoporosis or evaluating novel therapeutic interventions, we have the perfect model to support your scientific goals. Choose us for your osteoporosis research and experience the difference our expertise and dedication can make in advancing your preclinical research.
Osteoporosis, a common bone disorder, is characterized by an imbalance between bone resorption and bone formation, leading to a net loss of bone mineral density (BMD). This condition increases the risk of fractures, particularly in the hip, spine, and forearm. Multiple risk factors have been identified, including sex hormones, aging, lifestyle factors, and the use of certain medications such as glucocorticoids and some anticonvulsants. Given the prevalence and impact of osteoporosis, numerous drugs and therapeutic approaches have been investigated for its treatment.
Fig. 1 Pharmacological action sites for osteoporosis
To advance our understanding and develop effective treatments for osteoporosis, preclinical research utilizing osteoporosis animal models is crucial. These models mimic human disease and allow for the evaluation of potential therapies in a controlled setting.
Our Animal Models of Osteoporosis
Osteoporosis is a common bone disease characterized by low bone mass and structural deterioration of bone tissue, leading to an increased risk of fractures. This condition affects millions of people worldwide, particularly postmenopausal women and older adults. To accelerate the development of new therapies and to better understand the mechanisms underlying this disease, Creative Bioarray offers a range of osteoporosis models tailored to meet the specific needs of researchers. These models include:
- Ovariectomy (OVX)-Induced Osteoporosis Model
- Orchiectomy (ORX)-Induced Osteoporosis Model
- Glucocorticoid-Induced Osteoporosis (GIO) Model
Quotation and Ordering
At Creative Bioarray, you will find the most comprehensive preclinical services at the most competitive prices. We are willing to share our extensive experience in drug efficacy studies to help you achieve your research goals. Whether you're seeking guidance on study design, assistance with disease model development, or need help interpreting your data, we are here to support you every step of the way. If you are interested in our services, please feel free to contact us at any time or submit an inquiry to us directly.
Reference
- Kim, B., et al. Osteoporosis therapies and their mechanisms of action. Experimental and therapeutic medicine, 2021, 22(6): 1-14.
For research use only. Not for any other purpose.
